Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM- stimulated bovine cartilage  M. Durigova, M.Sc., P. Soucy, B.Sc., K. Fushimi,

Slides:



Advertisements
Similar presentations
Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: a fetuin–MGP protein complex is assembled in vesicles shed from normal.
Advertisements

Fig. 1 Schematic representation of s(P)RR generation
VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 by Koichi Kokame, Masanori Matsumoto, Yoshihiro.
Volume 32, Issue 1, Pages (October 2008)
MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation – divergence in pathways leading to aggrecanase and MMP-mediated.
Volume 13, Issue 2, Pages (January 2004)
The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation  N. Charni-Ben Tabassi,
M. Z. Ilic, Ph. D. , B. Martinac, Ph. D. , T. Samiric, Ph. D. , C. J
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments  A. Struglics,
PHAPI, CAS, and Hsp70 Promote Apoptosome Formation by Preventing Apaf-1 Aggregation and Enhancing Nucleotide Exchange on Apaf-1  Hyun-Eui Kim, Xuejun.
Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: a fetuin–MGP protein complex is assembled in vesicles shed from normal.
MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan.
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope.
Articular chondrocytes derived from distinct tissue zones differentially respond to in vitro oscillatory tensile loading  E.J. Vanderploeg, Ph.D., C.G.
Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-α but not IL-1β treatment at a post-transcriptional level in bovine cartilage.
J. S. Mort, F. Beaudry, K. Théroux, A. A. Emmott, H. Richard, W. D
W. H. Busby, Ph. D. , S. A. Yocum, Ph. D. , M. Rowland, D. Kellner, S
Aggrecanolysis in human osteoarthritis: confocal localization and biochemical characterization of ADAMTS5–hyaluronan complexes in articular cartilages 
Estimation of the identity of proteolytic aggrecan fragments using PAGE migration and Western immunoblot  A. Struglics, Ph.D., S. Larsson, B.Sc., L.S.
An ARGS-aggrecan assay for analysis in blood and synovial fluid
Spine degeneration in a murine model of chronic human tobacco smokers
Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor  P.S. Chockalingam, W. Sun, M.A. Rivera-Bermudez,
Volume 8, Issue 4, Pages (April 2015)
Direct Activation of Gastric H,K-ATPase by N-Terminal Protein Kinase C Phosphorylation. Comparison of the Acute Regulation Mechanisms of H,K-ATPase and.
Zonal differences in meniscus matrix turnover and cytokine response
Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration  C.B. Little,
Inhibition of lysyl oxidase activity can delay phenotypic modulation of chondrocytes in two-dimensional culture  J. Farjanel, Ph.D., S. Sève, Ph.D., A.
Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures  Anna Johnson, Roger Smith, Tore Saxne,
10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin 
P.A. Torzilli, M. Bhargava, S. Park, C.T.C. Chen 
Cartilage degradation independent of MMP/aggrecanases
FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer  T.L. Vincent, M.D., Ph.D.,
Involvement of Gas7 along the ERK1/2 MAP kinase and SOX9 pathway in chondrogenesis of human marrow-derived mesenchymal stem cells  Y. Chang, M.D., S.W.N.
E. Rodriguez, B.Sc., Dr. P. Roughley, Ph.D. 
N Burton-Wurster, Ph. D. , W Liu, M. D. , Ph. D. , G. L Matthews, D. V
Molecular Therapy - Methods & Clinical Development
Analysis of Proteins with Caseinolytic Activity in a Human Stratum Corneum Extract Revealed a Yet Unidentified Cysteine Protease and Identified the So-Called.
M.Brandon Parrott, Michael A. Barry  Molecular Therapy 
Proteolytic Mapping of the Adeno-associated Virus Capsid
Mixtures of glucosamine and chondroitin sulfate reverse fibronectin fragment mediated damage to cartilage more effectively than either agent alone  G.A.
Homo-Oligomerization of Human Corneodesmosin Is Mediated by Its N-Terminal Glycine Loop Domain  Cécile Caubet, Nathalie Jonca, Frédéric Lopez, Jean-Pierre.
Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and.
Autoantibodies in a Subgroup of Patients with Linear IgA Disease React with the NC16A Domain of BP1801  Detlef Zillikens, Karin Herzele, Matthias Georgi,
T Cell Stimulating Stratum Corneum Antigens: Characterization by Chromatography and Electrophoresis Indicates Limited Diversity  Jonathan M. Hales, Richard.
Calnexin Controls the STAT3-Mediated Transcriptional Response to EGF
A stable isotope method for the simultaneous measurement of matrix synthesis and cell proliferation in articular cartilage in vivo  K.W. Li, S.A. Siraj,
L. C. Davies, B. Sc. , Ph. D. , E. J. Blain, B. Sc. , Ph. D. , B
Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin  Y. Luan, Ph.D., M.D., L. Kong, Ph.D.,
p53 Protein Exhibits 3′-to-5′ Exonuclease Activity
Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes 
Intra-articular injection of tumor necrosis factor-α in the rat: an acute and reversible in vivo model of cartilage proteoglycan degradation  A.M. Malfait,
Versican, a Major Hyaluronan-Binding Component in the Dermis, Loses its Hyaluronan- Binding Ability in Solar Elastosis  Keiko Hasegawa, Masahiko Yoneda,
Volume 13, Issue 2, Pages (January 2004)
M. Durigova, M.Sc., P.J. Roughley, Ph.D., J.S. Mort, Ph.D. 
Volume 90, Issue 4, Pages (August 1997)
Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β- stimulated chondrocytes – study in hypoxic alginate bead cultures 
Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage  P. Patwari, G. Gao, J.H.
Ruth Halaban, Elaine Cheng  Journal of Investigative Dermatology 
Volume 95, Issue 2, Pages (October 1998)
IL-37 diminishes proteoglycan loss in human OA cartilage: donor-specific link between IL-37 and MMP-3  E.W. van Geffen, A.P.M. van Caam, W. Schreurs,
The cleavage of biglycan by aggrecanases
Malondialdehyde oxidation of cartilage collagen by chondrocytes
Human Pre-mRNA Cleavage Factor Im Is Related to Spliceosomal SR Proteins and Can Be Reconstituted In Vitro from Recombinant Subunits  Ursula Rüegsegger,
Salivary Lactoferrin Is Recognized by the Human Herpesvirus-8
Downregulation of inhibitor of apoptosis proteins in apoptotic human chondrocytes treated with tumor necrosis factor-alpha and actinomycin D  Dr F. Yoshimura,
Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration  M.J. Janusz, Ph.D., C.B. Little,
Proteolytic Mapping of the Adeno-associated Virus Capsid
Histone H4 Is a Major Component of the Antimicrobial Action of Human Sebocytes  Dong-Youn Lee, Chun-Ming Huang, Teruaki Nakatsuji, Diane Thiboutot, Sun-Ah.
Removal of O-linked and N-linked oligosaccharides is required for optimum detection of NITEGE neoepitope on ADAMTS4-digested fetal aggrecans: implications.
N-Terminal Palmitoylation of PSD-95 Regulates Association with Cell Membranes and Interaction with K+ Channel Kv1.4  J.Rick Topinka, David S Bredt  Neuron 
Presentation transcript:

Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM- stimulated bovine cartilage  M. Durigova, M.Sc., P. Soucy, B.Sc., K. Fushimi, Ph.D., Dr., H. Nagase, Ph.D., Dr., J.S. Mort, Ph.D., Dr., P.J. Roughley, Ph.D., Dr.  Osteoarthritis and Cartilage  Volume 16, Issue 10, Pages 1245-1252 (October 2008) DOI: 10.1016/j.joca.2008.02.013 Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Aggrecanase cleavage sites in bovine aggrecan. (A) Schematic representation of the bovine aggrecan core protein and its constituent domains: G1, IGD, G2 and G3, and the GAG-substituted domains: KS and CS-1 and CS-2 domains. Previously described aggrecanase cleavage sites are indicated by numbered arrows (1–5). Position of the additional aggrecanase-mediated cleavage site described in the present work is indicated by the dashed arrow (6). (B) Sites cleaved by aggrecanases. Cleavage site is indicated by an arrow and the position of the P1 glutamic acid residue in the bovine aggrecan sequence is also indicated. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Release of G3-containing fragments from bovine cartilage explant cultures. Bovine cartilage explants were cultured in the presence of IL-1β and OSM over a 4-day period. Culture medium was collected at day 2 and day 4, treated with keratanase II and chondroitinase ABC, analyzed by SDS/PAGE and immunoblotting using an antibody recognizing the G3 domain of aggrecan. Material released from equal amounts of cartilage explants was loaded onto the gel. Lane 1, control day 2; lane 2, IL-1β+OSM day 2; lane 3, IL-1β+OSM day 4. Migration positions of molecular weight markers are indicated on the left. Migration position of the additional G3-bearing fragment is indicated by an arrow. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 Purification of G3-containing aggrecan fragments by ion-exchange chromatography. (A) Culture media from day 2 and day 4 of IL-1β/OSM-treated explant cultures were pooled and loaded onto a DEAE-Sepharose column pre-equilibrated in 50-mM Tris, 0.15-M NaCl, pH 7.5. Bound aggrecan material was retrieved by step elution with 0.3-M and 1-M NaCl. Protein content in the collected 1-ml fractions was estimated by measuring absorbance at 280nm. (B) Aliquots of the fractions were deglycosylated and analyzed by SDS/PAGE and western blotting using anti-G3 antibody. Migration positions of molecular weight markers are indicated on the left. Migration position of the G3-bearing fragment of interest is indicated by an arrow. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 Amino acid sequence analysis of G3-containing aggrecan fragment. Fraction number 98 [see Fig. 3(B)] containing the G3 product of interest was treated with keratanase II and chondroitinase ABC. The sample was run on a 4–12% Bis–Tris Novex gels and transferred to a PVDF membrane. The Coomassie Blue-stained band of interest (marked by an arrow) was excised and analyzed by automated Edman degradation sequencing. The determined N-terminal sequence is indicated. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 Digestion of fetal bovine aggrecan with aggrecanases. Purified fetal bovine aggrecan (2mg/ml) was digested with recombinant full-length human ADAMTS-4 or ADAMTS-5 (5nM) for 24h at 37°C. The samples were then treated with keratanase II and chondroitinase ABC, then analyzed by SDS/PAGE and immunoblotting using either an anti-aggrecan G3 antibody (A) or an anti-neoepitope antibody directed against the new N-terminus of the G3 fragment (B). Lane 1, undigested aggrecan; lane 2, aggrecan digested with ADAMTS-4; lane 3, aggrecan digested with ADAMTS-5; lane 4, culture media from IL-1β/OSM-treated bovine explants collected at day 4. Migration positions of molecular weight markers are indicated on the left. Migration position of the G3-bearing fragment of interest is indicated by an arrow. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 Digestion of fetal bovine aggrecan by ADAMTS-5: a time-course study. Purified aggrecan (2mg/ml) was digested with recombinant human ADAMTS-5 (1nM) for 1, 3, 6 or 18h at 37°C. The samples were then treated with keratanase II and chondroitinase ABC, and analyzed by SDS/PAGE and immunoblotting using an anti-aggrecan G3 antibody. Lane 1, undigested aggrecan; lane 2, aggrecan digested with ADAMTS-5 for 1h; lane 3, aggrecan digested with ADAMTS-5 for 3h; lane 4, aggrecan digested with ADAMTS-5 for 6h; lane 5, aggrecan digested with ADAMTS-5 for 18h. Migration positions of molecular weight markers are indicated on the left. Migration position of the G3-bearing fragment of interest is indicated by an arrow. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 7 Analysis of CS and KS presence of G3-containing aggrecan fragment. ADAMTS-5 digests of fetal bovine aggrecan were treated with either keratanase II or chondroitinase ABC, or both enzymes. Sample were then analyzed by SDS/PAGE on 4–12% Bis–Tris Novex gels and immunoblotting using either an anti-aggrecan G3 antibody or an anti-neoepitope antibody directed against the new N-terminus of the G3 fragment. Migration positions of molecular weight markers are indicated on the left. Migration position of the G3-bearing fragment of interest is indicated by an arrow. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions

Fig. 8 Sequence comparison between different species at the C-terminal aggrecanase cleavage site. Bovine, human, dog, mouse and rat aggrecan amino acid sequences at the cleavage site were aligned. P1 indicates the first amino acid upstream of the scissile bond; P1′ represents the first amino acid downstream of the scissile bond. Amino acids are represented by their respective single letter code. Osteoarthritis and Cartilage 2008 16, 1245-1252DOI: (10.1016/j.joca.2008.02.013) Copyright © 2008 Osteoarthritis Research Society International Terms and Conditions